• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Hope for long-term antidepressant users as study shows half can taper off drugs with simple support

by
June 26, 2024
in Science News
Reading Time: 3 mins read
0
Patients on long-term antidepressants
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Nearly half of long-term antidepressant users can quit the drugs with GP support and access to internet or telephone helplines alone, a study has revealed.

Patients on long-term antidepressants

Credit: University of Southampton

Nearly half of long-term antidepressant users can quit the drugs with GP support and access to internet or telephone helplines alone, a study has revealed.

Scientists found that more than 40 per cent of people who were well and not at risk of relapse managed to come off the medication with advice from their doctors.

They also discovered patients who could access online support and psychologists by phone had lower rates of depression, fewer withdrawal symptoms, and reported better mental wellbeing.

More than ten per cent of adults in the UK are taking antidepressants for depression with more than half using them for longer than two years, according to NHS figures.

The study, which was published in JAMA Network Open, was led by the universities of Southampton, Liverpool and Hull York Medical School.

Professor Tony Kendrick from Southampton was the lead author of the research, funded by the National Institute for Health and Care Research (NIHR).

He said the findings are significant as they show high numbers of patients withdrawing from the drugs do not need costly intense therapy sessions.

He added: “This approach could eliminate the risk of serious side-effects for patients using antidepressants for long periods who have concerns about withdrawal.

“Offering patients internet and psychologist telephone support is also cost-effective for the NHS.

“Our findings show that support not only improves patient outcomes but also tends to reduce the burden on primary health care while people taper off antidepressants.”

The scientists behind the study enrolled 330 adults who have been taking the medication for more than a year for a first episode of depression, or more than two years for a recurrence of the illness.

Co-author Una Macleod, Professor of Primary Care Medicine at Hull York Medical School, said: “Many patients are taking antidepressants for depression for longer than two years, when they probably no longer need them.

“The evidence in our study is clear and suggests the UK should establish a national helpline, by phone and online, to help people intending to come off the medication.”

The new study is the latest in a seven-year research programme, named REDUCE, led by the universities to investigate the long-term effects of withdrawing from antidepressants.

Professor of General Practice Mark Gabbay, a co-author from the University of Liverpool, said the research shows that many patients do not need intense face-to-face therapy sessions while withdrawing.

He added: “This is the first study to demonstrate that stopping inappropriate long-term antidepressant treatment is possible at scale without psychological therapy.

“Antidepressants are recommended only for up to two years in most cases, and people are running the risk of increasing side effects as they get older.

“From our findings, we are calling for active family practitioner reviews for antidepressant discontinuation to be promoted.”

Read the study in full at jamanetwork.com/journals/jamanetworkopen/fullarticle/2820202.



Journal

JAMA Network Open

DOI

10.1001/jamanetworkopen.2024.18383

Method of Research

Randomized controlled/clinical trial

Subject of Research

People

Article Title

Internet and telephone support for discontinuing long-term antidepressants

Article Publication Date

24-Jun-2024

Share12Tweet8Share2ShareShareShare2

Related Posts

Enhancing Early Breast Cancer Care Through Patient Navigation

November 8, 2025

Enhancing Early Breast Cancer Care Through Patient Navigation

November 8, 2025

Unraveling Momordin Ic’s Impact on Stp1 Activity

November 8, 2025

S100A13 Key to Osteosarcoma Prognosis

November 8, 2025

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    314 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    206 shares
    Share 82 Tweet 52
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1302 shares
    Share 520 Tweet 325
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    139 shares
    Share 56 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Enhancing Early Breast Cancer Care Through Patient Navigation

Enhancing Early Breast Cancer Care Through Patient Navigation

Unraveling Momordin Ic’s Impact on Stp1 Activity

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.